Cleared Traditional

K861950 - THE FM-212A BIOFEEDBACK UNIT

K861950 is an FDA 510(k) clearance for THE FM-212A BIOFEEDBACK UNIT, manufactured by Hosa Technology, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 337-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
337d
Days
Class 2
Risk

K861950 is an FDA 510(k) clearance for the THE FM-212A BIOFEEDBACK UNIT. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Hosa Technology, Inc. (Cerritos, US). The FDA issued a Cleared decision on April 22, 1987 after a review of 337 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hosa Technology, Inc. devices

FDA 510(k) Submission Details - K861950

510(k) Number K861950 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 1986
Decision Date April 22, 1987
Days to Decision 337 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
189d slower than avg
Panel avg: 148d · This submission: 337d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 57
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K861950.
MYODAC2 BIOFEEDBACK DEVICE
K894840 · Thought Technology , Ltd. · Oct 1989
MYODAC
K883597 · Thought Technology , Ltd. · Nov 1988
MYOTRAC
K881416 · Thought Technology , Ltd. · Sep 1988
TEMP/SC 200T -SKIN CONDUCTANCE/SKIN TEMP BIOFEEDBA
K850642 · Thought Technology , Ltd. · May 1985
HR/BVP 100T HEART RATE MONITOR
K850643 · Thought Technology , Ltd. · May 1985
CALMTONE
K834519 · Thought Technology , Ltd. · Jan 1984